{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:00:45Z","timestamp":1759838445861},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00393-020-00891-3","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T14:02:47Z","timestamp":1602252167000},"page":"848-854","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Allgemeine Prinzipien des Impfens unter Immunsuppression"],"prefix":"10.1007","volume":"79","author":[{"given":"D.","family":"Schreiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"issue":"9","key":"891_CR1","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran\u00a0MF, Crowson\u00a0CS, Pond\u00a0GR et al (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46(9):2287\u20132293. https:\/\/doi.org\/10.1002\/art.10524","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 51","key":"891_CR2","first-page":"S35","volume":"26","author":"T Sokka","year":"2008","unstructured":"Sokka\u00a0T, Abelson\u00a0B, Pincus\u00a0T (2008) Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 26(5 Suppl 51):S35\u2013S61","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"891_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1177\/1352458510394397","volume":"17","author":"M Oikonen","year":"2011","unstructured":"Oikonen\u00a0M, Laaksonen\u00a0M, Aalto\u00a0V et al (2011) Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence. Mult Scler 17(6):672\u2013680. https:\/\/doi.org\/10.1177\/1352458510394397","journal-title":"Mult Scler"},{"issue":"31","key":"891_CR4","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1016\/j.vaccine.2015.06.012","volume":"33","author":"P Loubet","year":"2015","unstructured":"Loubet\u00a0P, Kern\u00e9is\u00a0S, Groh\u00a0M et\u00a0al (2015) Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a\u00a0large cohort of patients with secondary immune deficiency. Vaccine 33(31):3703\u20133708. https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.012","journal-title":"Vaccine"},{"issue":"1","key":"891_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cid\/ciw675","volume":"64","author":"B Neven","year":"2017","unstructured":"Neven\u00a0B, P\u00e9rot\u00a0P, Bruneau\u00a0J et\u00a0al (2017) Cutaneous and visceral chronic granulomatous disease triggered by a\u00a0rubella virus vaccine strain in children with primary Immunodeficiencies. Clin Infect Dis 64(1):83\u201386. https:\/\/doi.org\/10.1093\/cid\/ciw675","journal-title":"Clin Infect Dis"},{"issue":"6","key":"891_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00103-017-2555-4","volume":"60","author":"T Niehues","year":"2017","unstructured":"Niehues\u00a0T, Bogdan\u00a0C, Hecht\u00a0J et\u00a0al (2017) Impfen bei Immundefizienz: Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen (I) Grundlagenpapier. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60(6):674\u2013684. https:\/\/doi.org\/10.1007\/s00103-017-2555-4","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"891_CR7","doi-asserted-by":"publisher","unstructured":"Ehl\u00a0S, Bogdan\u00a0C, Niehues\u00a0T et al (2018) Impfen bei Immundefizienz: Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen. (II) Impfen bei 1.\u00a0Prim\u00e4ren Immundefekterkrankungen und 2.\u00a0HIV-Infektion. Bundesgesundheitsbl 61:1034\u20131051. https:\/\/doi.org\/10.1007\/s00103-018-2761-8. (Erratum zu: Impfen bei Immundefizienz: Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen. (II)\u00a0Impfen bei 1.\u00a0Prim\u00e4ren Immundefekterkrankungen und 2.\u00a0HIV-Infektion. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 61(10):1307\u20131308. https:\/\/doi.org\/10.1007\/s00103-018-2807-y)","DOI":"10.1007\/s00103-018-2761-8 10.1007\/s00103-018-2807-y"},{"issue":"5","key":"891_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s00103-020-03123-w","volume":"63","author":"H-J Laws","year":"2020","unstructured":"Laws\u00a0H\u2011J, Baumann\u00a0U, Bogdan\u00a0C et al (2020) Impfen bei Immundefizienz: Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen. (III) Impfen bei h\u00e4matologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 63(5):588\u2013644. https:\/\/doi.org\/10.1007\/s00103-020-03123-w","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"4","key":"891_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00103-019-02905-1","volume":"62","author":"N Wagner","year":"2019","unstructured":"Wagner\u00a0N, Assmus\u00a0F, Arendt\u00a0G et al (2019) Impfen bei Immundefizienz: Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entz\u00fcndlichen Erkrankungen und unter immunmodulatorischer Therapie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 62(4):494\u2013515. https:\/\/doi.org\/10.1007\/s00103-019-02905-1","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"6","key":"891_CR10","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.4161\/hv.28350","volume":"10","author":"R Mitchell","year":"2014","unstructured":"Mitchell\u00a0R, Kelly\u00a0DF, Pollard\u00a0AJ et al (2014) Polysaccharide-specific B cell responses to vaccination in humans. Hum Vaccin Immunother 10(6):1661\u20131668. https:\/\/doi.org\/10.4161\/hv.28350","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"891_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1136\/ard.2005.043943","volume":"65","author":"A Holvast","year":"2006","unstructured":"Holvast\u00a0A, Huckriede\u00a0A, Wilschut\u00a0J et\u00a0al (2006) Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 65(7):913\u2013918. https:\/\/doi.org\/10.1136\/ard.2005.043943","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"891_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13075-015-0662-x","volume":"17","author":"K Migita","year":"2015","unstructured":"Migita\u00a0K, Akeda\u00a0Y, Akazawa\u00a0M et\u00a0al (2015) Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus. Arthritis Res Ther 17(1):149. https:\/\/doi.org\/10.1186\/s13075-015-0662-x","journal-title":"Arthritis Res Ther"},{"key":"891_CR13","volume-title":"Robert Koch-Intitut Epidemiologisches Bulletin","author":"Robert Koch-Intitut","year":"2019","unstructured":"Robert Koch-Intitut (2019) Robert Koch-Intitut Epidemiologisches Bulletin Bd. 34"},{"issue":"7","key":"891_CR14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/cid\/ciu970","volume":"60","author":"P Bhalla","year":"2015","unstructured":"Bhalla\u00a0P, Forrest\u00a0GN, Gershon\u00a0M et al (2015) Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation. Clin Infect Dis 60(7):1068\u20131074. https:\/\/doi.org\/10.1093\/cid\/ciu970","journal-title":"Clin Infect Dis"},{"issue":"44","key":"891_CR15","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1016\/j.vaccine.2014.08.051","volume":"32","author":"SJ Seligman","year":"2014","unstructured":"Seligman\u00a0SJ (2014) Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD). Vaccine 32(44):5769\u20135775. https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.051","journal-title":"Vaccine"},{"key":"891_CR16","doi-asserted-by":"publisher","DOI":"10.17886\/EpiBull-2016-055.1","author":"St\u00e4ndige Impfkommission","year":"2016","unstructured":"St\u00e4ndige Impfkommission (2016) Wissenschaftliche Begr\u00fcndung f\u00fcr die Aktualisierung der Empfehlungen zur Indikationsimpfung gegen Pneumokokken f\u00fcr Risikogruppen. Epidemiol Bull. https:\/\/doi.org\/10.17886\/EpiBull-2016-055.1","journal-title":"Epidemiol Bull"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00891-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-020-00891-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00891-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T06:44:31Z","timestamp":1633848271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-020-00891-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1007\/s00393-020-00891-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"24 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Schreiner und F.\u00a0Zepp geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}